概述
-
货号
DHD14298
-
描述
Cantuzumab ravtansine is an ADC consisting of a CanAg-directed antibody and DM4 that has extensive antitumor efficacy in a series of CanAg-positive human tumor xenografts.
-
种属反应性
Human -
克隆类型
Monoclonal -
靶标
PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin -
浓度
1 mg/ml -
内毒素水平
Please contact with the lab for this information. -
纯度
>90% as determined by SEC. -
纯化方式
Purified by Ion Exchange Chromatography. -
克隆号
Cantuzumab ravtansine
-
应用
Research Grade Biosimilar -
状态
Liquid -
稳定性和存储
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. -
别名
C242-DM4
图片
参考文献
评价
